Ronald H. W. Cooper
Net Worth
Last updated:
What is Ronald H. W. Cooper net worth?
The estimated net worth of Mr. Ronald H. W. Cooper is at least $8,118,906 as of 23 Jan 2023. He has earned $208,906 from insider trading and has received compensation worth at least $7,910,000 in Albireo Pharma, Inc..
What is the salary of Ronald H. W. Cooper?
Mr. Ronald H. W. Cooper salary is $1,130,000 per year as Chief Executive Officer, Pres & Director in Albireo Pharma, Inc..
How old is Ronald H. W. Cooper?
Mr. Ronald H. W. Cooper is 62 years old, born in 1963.
What stocks does Ronald H. W. Cooper currently own?
As insider, Mr. Ronald H. W. Cooper owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Albireo Pharma, Inc. (ALBO) | Chief Executive Officer, Pres & Director | 57,444 | $0 | $0 |
What does Albireo Pharma, Inc. do?
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as well as in Phase III clinical trial for treating biliary atresia, alagille syndrome, and rare and life-threatening disorder to children; and Elobixibat for the treatment of chronic constipation and other functional diseases. It also engages in the developing of A3907, which is in Phase I clinical trial for the treatment of adult liver diseases; and A2342, a preclinical candidate to treat adult viral and liver diseases. The company has a license agreement with EA Pharma Co., Ltd. for the development and commercialization of elobixibat. Albireo Pharma, Inc. is headquartered in Boston, Massachusetts.
Ronald H. W. Cooper insider trading
Albireo Pharma, Inc.
Mr. Ronald H. W. Cooper has made 5 insider trades between 2018-2023, according to the Form 4 filled with the SEC. Most recently he sold 1,057 units of ALBO stock worth $46,297 on 23 Jan 2023.
The largest trade he's ever made was exercising 11,973 units of ALBO stock on 17 Sep 2021. As of 23 Jan 2023 he still owns at least 57,444 units of ALBO stock.
Albireo Pharma key executives
Albireo Pharma, Inc. executives and other stock owners filed with the SEC:
- Mr. Ronald H. W. Cooper (62) Chief Executive Officer, Pres & Director
- Ms. Martha J. Carter (73) Chief Regulatory Officer